During the last session, Hims & Hers Health Inc (NYSE:HIMS)’s traded shares were 18.31 million, with the beta value of the company hitting 1.10. At the end of the trading day, the stock’s price was $21.79, reflecting an intraday loss of -7.39% or -$1.74. The 52-week high for the HIMS share is $30.44, that puts it down -39.7 from that peak though still a striking 65.58% gain since the share price plummeted to a 52-week low of $7.50. The company’s market capitalization is $4.76B, and the average intraday trading volume over the past 10 days was 28.58 million shares, and the average trade volume was 13.06 million shares over the past three months.
Hims & Hers Health Inc (HIMS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.29. HIMS has a Sell rating from 0 analyst(s) out of 13 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.22.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hims & Hers Health Inc (NYSE:HIMS) trade information
Hims & Hers Health Inc (HIMS) registered a -7.39% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.39% in intraday trading to $21.79, hitting a weekly high. The stock’s 5-day price performance is -21.05%, and it has moved by -7.63% in 30 days. Based on these gigs, the overall price performance for the year is 181.52%. The short interest in Hims & Hers Health Inc (NYSE:HIMS) is 33.84 million shares and it means that shorts have 2.66 day(s) to cover.
The consensus price target of analysts on Wall Street is $23, which implies an increase of 5.26% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $28 respectively. As a result, HIMS is trading at a discount of -28.5% off the target high and 63.29% off the low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Statistics show that Hims & Hers Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Hims & Hers Health Inc (HIMS) shares have gone up 34.76% during the last six months, with a year-to-date growth rate more than the industry average at 600.00% against 25.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 310.31% this quarter and then jump 76.30% in the quarter after that. In the rating firms’ projections, revenue will increase 67.56% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 469.48M as predicted by 11 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 480.43M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 246.62M and 278.17M respectively. In this case, analysts expect current quarter sales to grow by 90.37% and then jump by 72.71% in the coming quarter.
While earnings are projected to return 824.74% in 2024.
HIMS Dividends
Hims & Hers Health Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Hims & Hers Health Inc insiders own 11.39% of total outstanding shares while institutional holders control 66.19%, with the float percentage being 74.70%. VANGUARD GROUP INC is the largest shareholder of the company, while 422.0 institutions own stock in it. As of 2024-06-30, the company held over 16.47 million shares (or 7.7166% of all shares), a total value of $332.55 million in shares.
The next largest institutional holding, with 14.57 million shares, is of BLACKROCK INC.’s that is approximately 6.8278% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $294.25 million.
